The VPS35 D620N mutation impairs retromer complex assembly at endosomal membranes, disrupting the retrieval of GCase-containing vesicles from endosomes back to the lysosome. Under physiological conditions, the retromer recognizes a specific sorting motif on GCase (possibly within its cytosolic tail) and directs it toward the lysosome via the CLIP1-positive tubular network. The VPS35 D620N mutation specifically destabilizes the retromer-cargo interaction without affecting overall complex integrity, as demonstrated by crystallographic studies showing the mutation lies at the SNX3-binding interface. In dopaminergic neurons, this creates a partial GCase trafficking defect that reduces lysosomal GCase activity by approximately 30-40%, a threshold below which glucosylceramide begins to accumulate. Crucially, GBA1 heterozygous mutation carriers (p.N370S) already have ~50% reduced GCase activity; when combined with VPS35 dysfunction, the cumulative effect pushes lysosomal GCase below the aggregation threshold.
...Curated pathway from expert analysis
flowchart TD
A["VPS35 D620N Retromer Defect<br/>Endosomal Sorting Impaired"]
B["GCase Retrieval Bottleneck<br/>Lysosomal Delivery Reduced"]
C["GBA1 Mutation Burden<br/>Lower Enzyme Reserve"]
D["GlcCer Accumulation<br/>Lysosomal Membrane Stress"]
E["SNCA Degradation Failure<br/>CMA and Macroautophagy Burden"]
F["SNCA Aggregation<br/>Lewy Pathology Amplification"]
G["Synergistic PD Progression<br/>Retromer GBA1 Axis"]
A --> B
C --> D
B --> D
D --> E
E --> F
F --> G
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9aNo linked papers recorded for this hypothesis yet.
No curated PDB or AlphaFold mapping for VPS35 yet. Search RCSB →
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for VPS35.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
No resource usage or linked notebooks recorded for this hypothesis yet.
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF C57BL/6J mice are engineered to carry both VPS35 D620N/+ and GBA1 p.N370S/+ knock-in mutations (double mutants) and aged to 12 months, THEN the double-mutant cohort will display synergistic increas | Double-mutant mice will show synergistic SNCA aggregation: striatal pS129 SNCA signal >4.5-fold above WT (vs. ~2.5-fold for each single mutant), with >60% of do | — no observation — | pending | 0.68 |
| IF iPSC-derived VPS35 D620N/+ / GBA1 p.N370S/+ dopaminergic neurons are treated with CRISPRa-mediated NUMB overexpression (AAV9-NUMB-dCas9-VPR, MOI 5) for 14 days, THEN normalized lysosomal GCase acti | Retromer enhancement will rescue GCase trafficking: GCase activity in lysosomal fraction rises from ~30% of WT to >70% of WT, and GlcCer substrate accumulation | — no observation — | pending | 0.61 |